Skip to main content

Table 5 Creatinine values over time with actual and percent change from baseline by treatment

From: A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults

Creatinine (mg/dL)

Lab values over time

Change from baseline (actual and percent)

 

Baseline

Hour 24

Hour 72

Hour 120

to Hour 24

to Hour 72

to Hour 120

100 mg IV Ibuprofen

Average

0.95

0.85

0.85

0.87

-.009

-6.4%

-0.09

-4.1%

-0.08

-1.9%

 

SD

0.26

0.21

0.21

0.30

0.23

25.6

0.33

37.0

0.40

48.7

 

N

31

30

29

28

30

30

29

29

28

28

 

Min

0.57

0.50

0.50

0.50

-0.60

-44.4%

-0.80

-50.0%

-0.90

-56.3%

 

Max

1.60

1.40

1.70

2.20

0.50

71.4%

1.00

142.9%

1.50

214.3%

200 mg IV Ibuprofen

Average

0.97

0.85

0.90

0.83

-0.12

-11.4%

-0.07

-6.0%

-0.08

-7.5%

 

SD

0.25

0.28

0.29

0.19

0.20

18.3

0.23

19.5

0.17

18.7

 

N

30

30

27

24

30

30

27

27

24

24

 

Min

0.60

0.11

0.50

0.50

-0.97

-89.8%

-0.60

-37.5%

-0.40

-28.6%

 

Max

1.60

1.50

1.70

1.30

0.20

15.4%

0.50

41.7%

0.30

50.0%

400 mg IV Ibuprofen

Average

0.97

0.97

1.07

1.05

0.00

-2.8%

0.11

6.7%

0.06

5.8%

 

SD

0.35

0.59

1.05

0.93

0.37

31.7

0.93

88.7

0.86

84.5

 

N

31

30

31

27

30

30

31

31

27

27

 

Min

0.40

0.30

0.30

0.30

-0.31

-34.1%

-0.30

-30.0%

-0.40

-33.3%

 

Max

2.10

3.20

5.81

5.28

1.39

136.3%

4.79

469.6%

4.26

417.6%

Placebo

Average

1.00

0.94

0.86

0.87

-0.06

-5.4%

-0.14

-10.3%

-0.16

-9.8%

 

SD

0.44

0.40

0.25

0.23

0.13

12.4

0.26

15.5

0.34

20.4

 

N

28

28

28

24

28

28

28

28

24

24

 

Min

0.60

0.42

0.50

0.50

-0.30

-33.3%

-1.10

-46.7%

-1.30

-53.3%

 

Max

2.80

2.50

1.70

1.50

0.20

18.2%

0.20

25.0%

0.30

37.5%